IT1256022B - Preparazioni farmaceutiche stabili di nicorandil - Google Patents

Preparazioni farmaceutiche stabili di nicorandil

Info

Publication number
IT1256022B
IT1256022B ITMI921413A ITMI921413A IT1256022B IT 1256022 B IT1256022 B IT 1256022B IT MI921413 A ITMI921413 A IT MI921413A IT MI921413 A ITMI921413 A IT MI921413A IT 1256022 B IT1256022 B IT 1256022B
Authority
IT
Italy
Prior art keywords
nicorandil
pharmaceutical preparations
stable pharmaceutical
polydimethylsiloxanes
stable
Prior art date
Application number
ITMI921413A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI921413A0 publication Critical patent/ITMI921413A0/it
Priority to ITMI921413A priority Critical patent/IT1256022B/it
Priority to MX9303165A priority patent/MX9303165A/es
Priority to JP5133290A priority patent/JP2893307B2/ja
Priority to KR1019930010224A priority patent/KR100196212B1/ko
Priority to ES93304427T priority patent/ES2153835T3/es
Priority to DE69329691T priority patent/DE69329691T2/de
Priority to US08/073,054 priority patent/US5580576A/en
Priority to AT93304427T priority patent/ATE197671T1/de
Priority to EP93304427A priority patent/EP0574221B1/en
Priority to PT93304427T priority patent/PT574221E/pt
Publication of ITMI921413A1 publication Critical patent/ITMI921413A1/it
Application granted granted Critical
Publication of IT1256022B publication Critical patent/IT1256022B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composizioni stabili di nicorandil sono state ottenute preparando sospensioni di principio attivo In polidimetilsilossani (dimeticone o simeticone) a catena lineare e a media-bassa densità per uso farmaceutico, con le quali sono state riempite capsule di gelatina dura o molle.I polidimetilsilossani hanno mostrato di essere chimicamente compatibili con nicorandil e di preservare efficacemente dall'umidità le preparazioni farmaceutiche così ottenute, rendendole più stabili per i normali tempi di conservazione.
ITMI921413A 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil IT1256022B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil
MX9303165A MX9303165A (es) 1992-06-08 1993-05-28 Preparaciones farmaceuticas estables de nicorandil
JP5133290A JP2893307B2 (ja) 1992-06-08 1993-06-03 ニコランジルの製薬的に安定な製剤
KR1019930010224A KR100196212B1 (ko) 1992-06-08 1993-06-07 니코란딜을 함유하는 안정한 약제조성물
ES93304427T ES2153835T3 (es) 1992-06-08 1993-06-08 Formulaciones farmaceuticas estables a base de nicorandil.
DE69329691T DE69329691T2 (de) 1992-06-08 1993-06-08 Pharmazeutische stabile Nicorandil-Formulierungen
US08/073,054 US5580576A (en) 1992-06-08 1993-06-08 Pharmaceutically/storage-stable nicorandil formulations
AT93304427T ATE197671T1 (de) 1992-06-08 1993-06-08 Pharmazeutische stabile nicorandil-formulierungen
EP93304427A EP0574221B1 (en) 1992-06-08 1993-06-08 Pharmaceutical stable formulations of nicorandil
PT93304427T PT574221E (pt) 1992-06-08 1993-06-08 Formulacoes farmaceuticas estaveis a base de nicorandil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil

Publications (3)

Publication Number Publication Date
ITMI921413A0 ITMI921413A0 (it) 1992-06-08
ITMI921413A1 ITMI921413A1 (it) 1993-12-08
IT1256022B true IT1256022B (it) 1995-11-20

Family

ID=11363474

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil

Country Status (10)

Country Link
US (1) US5580576A (it)
EP (1) EP0574221B1 (it)
JP (1) JP2893307B2 (it)
KR (1) KR100196212B1 (it)
AT (1) ATE197671T1 (it)
DE (1) DE69329691T2 (it)
ES (1) ES2153835T3 (it)
IT (1) IT1256022B (it)
MX (1) MX9303165A (it)
PT (1) PT574221E (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129673A (en) * 1998-06-08 2000-10-10 Advanced Monitors, Corp. Infrared thermometer
JP4472035B2 (ja) * 1998-06-17 2010-06-02 森下仁丹株式会社 長期保存安定性に優れたカプセル製剤
US20040151785A1 (en) * 1998-10-06 2004-08-05 Diamedica Inc. Method for treating insulin resistance through hepatic nitric oxide
ATE311883T1 (de) * 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
CN1913876B (zh) * 2003-12-09 2013-06-26 大日本住友制药株式会社 含药物的颗粒和包含这种颗粒的固体制剂
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
WO2012144943A1 (en) * 2011-04-18 2012-10-26 Lipidor Ab Liquid carrier for oral delivery of a pharmacologically active agent
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
PT2854841T (pt) 2012-06-04 2017-05-15 Diamedica Inc Isoformas de glicosilação da calicreína 1 em tecido humano
US11857608B2 (en) 2017-03-09 2024-01-02 Diamedica Inc. Dosage forms of tissue kallikrein 1
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006960A2 (en) * 1985-05-22 1986-12-04 Beecham Group P.L.C. Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPS6351326A (ja) * 1986-08-22 1988-03-04 Nisshin Flour Milling Co Ltd ニコランジル外用剤
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation

Also Published As

Publication number Publication date
EP0574221B1 (en) 2000-11-22
EP0574221A1 (en) 1993-12-15
US5580576A (en) 1996-12-03
KR100196212B1 (ko) 1999-06-15
DE69329691T2 (de) 2001-05-10
JP2893307B2 (ja) 1999-05-17
DE69329691D1 (de) 2000-12-28
ATE197671T1 (de) 2000-12-15
ITMI921413A1 (it) 1993-12-08
KR940000104A (ko) 1994-01-03
ITMI921413A0 (it) 1992-06-08
PT574221E (pt) 2001-04-30
MX9303165A (es) 1993-12-31
JPH0640916A (ja) 1994-02-15
ES2153835T3 (es) 2001-03-16

Similar Documents

Publication Publication Date Title
AU4355593A (en) Pharmaceutical preparation for intra-airway administration
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NZ501066A (en) Pharmaceutical formulations containing voriconazole and sulphobutylether beta-cyclodextrin
NZ229599A (en) Preparations of fat-soluble substances containing fish gelatine
AU2584192A (en) Bone-growth-stimulating composition
CA2070293A1 (en) Ophthalmic compositions and methods for preserving and using same
GEP20043299B (en) Physical Form of 5-chloro-N-[2-[4-[[[(cyclcohexylamino)-carbonyl]amino] sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Glyburide), Composition Containing the Same and its Use for II Type Diabetes
NO178261C (no) Substituerte diaminoftalimider og analoger, farmasöytiske preparater inneholdende dem samt deres anvendelse i medikamenter
SE8804628D0 (sv) New compounds
MX9303165A (es) Preparaciones farmaceuticas estables de nicorandil
IL89788A0 (en) 2,3,4-substituted imidazoles and 3,4,5-substituted 1,2,4-triazoles,their preparation and pharmaceutical compositions containing them
IL79084A0 (en) E-isomers of n alpha-(2-cyano-2-alkoximinoacetyl)-amino acid derivatives and peptides,their preparation and their use as pesticides
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
NO910080L (no) Svelgbare doseringsenheter omfattende kolloidalt vismut-subsitrat.
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
CA2158166A1 (en) Delayed release microtablet of .beta.-phenylpropiophenone derivatives
EP0647267A4 (en) STORAGE OF STEM CELLS AND LYMPHOCYTES.
IL89145A (en) 5-substituted ornithine derivatives and pharmaceutical compositions containing them
NL194463B (nl) Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat.
IL89571A0 (en) 3,4,5-substituted 4h-1,2,4-triazoles,their preparation and pharmaceutical compositions containing them
DK391982A (da) Sulfonylurinstoffer, deres fremstilling og anvendelse som farmaceutiske praeparater
IE873231L (en) Medicaments
IL76892A (en) Preparation of optically active azolyl-carbinol derivatives,optically active 2-(4-chlorophenoxymethyl)-3,3-dimethyl-1(1,2,4-triazol-1-yl)-2-butanol thus prepared and pharmaceutical compositions containing it
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
IL131703A0 (en) Pharmaceutical compositions in the form of soft gelatine capsule containing cyclosporin

Legal Events

Date Code Title Description
0001 Granted